NCT03395509

Brief Summary

This is an intersectional and interdisciplinary screening program in Viborg Municipality, including 67 years old citizens. This observational study will estimate the cost-effectiveness of a combined screening program for the following conditions: Abdominal aortic aneurysm, peripheral arterial disease, carotid plaque, hypertension, arrhythmia, and type-2-diabetes. Furthermore, the incidence of the outlined conditions will be described and so will the result of the intervention initiated (secondary medical prophylaxis, smoking cessation, introduction to nutritionally deficient diet etc.)

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,500

participants targeted

Target at P75+ for all trials

Timeline
40mo left

Started Aug 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Aug 2014Aug 2029

Study Start

First participant enrolled

August 1, 2014

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

March 15, 2017

Completed
10 months until next milestone

First Posted

Study publicly available on registry

January 10, 2018

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Last Updated

February 1, 2024

Status Verified

January 1, 2024

Enrollment Period

13 years

First QC Date

March 15, 2017

Last Update Submit

January 31, 2024

Conditions

Keywords

Mass screeningcardiovascular diseasediabetes

Outcome Measures

Primary Outcomes (6)

  • Baseline prevalence of peripheral arterial disease (PAD) in men and women aged 67 years from a population screening study on the Municipal of Viborg.

    Ankel Brachial Index

    Inclusion will take place from sep. 2014 to sep. 2020

  • Baseline prevalence of abdominal aortic aneurysm (AAA)

    Ultra sound examination (AP diameter (mm))

    Inclusion will take place from sep. 2014 to sep. 2020

  • Baseline prevalence of diabetes

    Bedside HbA1c

    Inclusion will take place from sep. 2014 to sep. 2020

  • Baseline prevalence of hypertension

    BP(mmhg)

    Inclusion will take place from sep. 2014 to sep. 2020

  • Baseline prevalence of cardiac arrythmia

    ECG

    Inclusion will take place from sep. 2014 to sep. 2020

  • Baseline prevalence of carotic plaques

    Ultra sound examination of A. carotis (IMT in mm)

    Inclusion will take place from sep. 2014 to sep. 2020

Secondary Outcomes (1)

  • The cost(-effectiveness) of the screening program

    5 years after ending inclusion

Eligibility Criteria

Age67 Years - 67 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Viborg municipality citizen are invited to the combined screening program around there 67th birthday. Participants with positive screening results are offered following up consultations and prophylactic interventions are initiated (secondary medical prophylaxis, smoking cessation, introduction to nutritionally deficient diet etc.) 67 years-old citizens from the surrounding municipalities without the offer of the combined screening are used as a control group (1 case: 5 controls).

You may qualify if:

  • All Viborg municipality citizen are invited to the combined screening program around there 67th birthday.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiovascular research Center (KVC), Viborg Hospital

Viborg, 8800, Denmark

Location

Related Publications (5)

  • Van Der Giessen D, Hogh A, Svenstrup D, Lindholt JS, Dahl M. Clinical relevance of screening for ECG abnormalities in 67-year-old Danes: a population-based cohort study from the Viborg Screening Programme (VISP). BMJ Open. 2025 Dec 23;15(12):e104169. doi: 10.1136/bmjopen-2025-104169.

  • Gras Hojgaard H, Hogh AL, Lindholt JS, Frederiksen K, Dahl M. Effect of nurse-led telephone follow-up to optimize adherence to preventive medication after screen-detected cardiovascular disease: a randomized controlled trial. Eur J Cardiovasc Nurs. 2025 Jul 21;24(5):748-759. doi: 10.1093/eurjcn/zvaf047.

  • Andersen JW, Hogh A, Lindholt JS, Sogaard R, Stovring H, Yderstraede KB, Sandbaek A, Dahl M. Impact of Population-Based Screening for Diabetes and Prediabetes Among 67-Year-Olds Using Point-of-Care HbA1c on Healthcare Ultilisation, Results from the VISP Cohort. Clin Epidemiol. 2025 Feb 5;17:75-85. doi: 10.2147/CLEP.S487825. eCollection 2025.

  • Dahl M, Andersen JW, Lindholt J, Krarup NT, Borregaard B, Uberg N, Hogh A. Prevalence of interarm blood pressure difference is notably higher in women; the Viborg population-based screening program (VISP). BMC Public Health. 2024 Jul 12;24(1):1868. doi: 10.1186/s12889-024-19388-8.

  • Hogh A, Lindholt JS, Sogaard R, Refsgaard J, Svenstrup D, Moeslund NJ, Bredsgaard M, Dahl M. Protocol for a cohort study to evaluate the effectiveness and cost-effectiveness of general population screening for cardiovascular disease: the Viborg Screening Programme (VISP). BMJ Open. 2023 Feb 28;13(2):e063335. doi: 10.1136/bmjopen-2022-063335.

MeSH Terms

Conditions

Aortic Aneurysm, AbdominalHypertensionPeripheral Arterial DiseaseArrhythmias, CardiacDiabetes MellitusCarotid Artery DiseasesCardiovascular Diseases

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesAortic DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesPeripheral Vascular DiseasesHeart DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Annette Høgh, MD, PhD

    Steering Committee

    STUDY CHAIR
  • Marie Dahl, MSc(nurse)

    Steering Committee

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Associated professor

Study Record Dates

First Submitted

March 15, 2017

First Posted

January 10, 2018

Study Start

August 1, 2014

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2029

Last Updated

February 1, 2024

Record last verified: 2024-01

Locations